Skip to main content
. 2019 Sep 13;42(5):260–263. doi: 10.1097/NAN.0000000000000341

TABLE 2. Summary of Treatment-Emergent Adverse Events.

Category 30-min IV Infusion HTX-019 130 mg (N = 147)
Patients with ≥1 TEAE, n (%) 9 (6)
Total number of TEAEs 14
HTX-019-related TEAEs 0
TEAE, n (%)
Feeling hot 4 (3)
Dizziness 2 (1)
Pruritusa 2 (1)
Nausea 1 (1)
Shortness of breath 1 (1)
Feeling weird 1 (1)
Chest tightness 1 (1)
Lower back pain 1 (1)
Erythema 1 (1)

Abbreviations: IV, intravenous; min, minute; TEAE treatment-emergent adverse event.

aPruritus includes itch and itchy scalp.